Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.5K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.5K
Cancer Vaccines01:30

Cancer Vaccines

1.4K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.4K
Cancer Survival Analysis01:21

Cancer Survival Analysis

843
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
843
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Chronic obstructive pulmonary disease: diagnosis, monitoring and chronic management in nursing practice.

British journal of nursing (Mark Allen Publishing)·2026
Same author

Neoadjuvant Fc-enhanced anti-CTLA-4 targets Tregs to augment androgen deprivation in high-risk prostate cancer: A randomized phase I trial.

Cell reports. Medicine·2026
Same author

The path forward for T cell engagers in patients with prostate cancer.

Journal for immunotherapy of cancer·2026
Same author

Estimating the long-term health outcomes of treatment with lecanemab in early Alzheimer's disease: a modelling study.

Journal of medical economics·2026
Same author

Implementation of a Multihospital Electronic Medical Record-Based Insulin Order Set to Reduce Hypoglycemic Events.

AACE endocrinology and diabetes·2025
Same author

Predictors of Long-Term Disease-Free Survival With Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer.

International journal of radiation oncology, biology, physics·2025
Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026
Same journal

Documenting hospice care.

Lancet (London, England)·2026
Same journal

After the wood chipper.

Lancet (London, England)·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
查看所有相关文章

相关实验视频

Updated: Apr 10, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

14.0K

前列腺癌是什么意思 前列腺癌是什么意思

Gerhardt Attard1, Chris Parker2, Ros A Eeles3

  • 1Division of Clinical Studies, The Institute of Cancer Research, London, UK; Prostate Cancer Targeted Therapy Group, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK.

Lancet (London, England)
|June 16, 2015
PubMed
概括
此摘要是机器生成的。

最近的前列腺癌研究推进了针对性查的遗传理解,并确定了个性化治疗的分子亚型. 转移性疾病的生存率有所改善,但最佳的新疗法测序需要进一步研究.

更多相关视频

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.3K
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

15.3K

相关实验视频

Last Updated: Apr 10, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

14.0K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.3K
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

15.3K

科学领域:

  • 在瘤学瘤学.
  • 遗传学 是一个遗传学.
  • 翻译研究是翻译研究.

背景情况:

  • 前列腺癌研究在过去十年里取得了重大进展.
  • 更好地了解家族性前列腺癌的遗传基础,包括高风险突变 (例如BRCA2,HOXB13) 和常见的低风险等位基因,有助于识别有风险的个体.
  • 目前使用前列腺特异性抗原 (PSA) 的前列腺癌查是有争议的,因为过度诊断和不必要的活检,尽管降低了死亡率.

研究的目的:

  • 审查最近前列腺癌研究的进展,重点关注遗传发现,分子亚型和治疗进展.
  • 突出管理局部化和转移性前列腺癌的挑战,特别是抵抗割的前列腺癌 (CRPC).
  • 强调迫切需要进一步的临床和翻译研究,以个性化前列腺癌管理.

主要方法:

  • 审查最近的科学文献和前列腺癌研究中的临床试验数据.
  • 对遗传发现的分析,包括全基因组关联研究 (GWAS) 和家族突变识别.
  • 对局部化和转移性前列腺癌的治疗策略的评估,包括CRPC治疗.

主要成果:

  • 识别关键的基因突变 (例如BRCA2,HOXB13) 和常见的等位基因,以进行向查.
  • 为了潜在的患者分层,将前列腺癌分类为分子亚型 (例如,ETS基因融合阳性,SPINK1过度表达,CHD1损失).
  • 转移性割抵抗性前列腺癌 (mCRPC) 的存活率大幅改善,除了多塞塔克塞尔外,还有五种新药的出现.

结论:

  • 遗传学和分子亚型化的进步为更个性化的前列腺癌查和管理提供了潜力.
  • 虽然mCRPC的生存率有所改善,但由于缺乏可靠的数据和高药物成本,最佳治疗选择和测序仍然具有挑战性.
  • 持续的临床和翻译研究对于改善和个性化前列腺癌护理至关重要.